Wetzel Investment Advisors, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Wetzel Investment Advisors, Inc.
- $176 Million
- Q1 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 2,400 shares of MIRM stock, worth $103,992. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,400
Previous 1,400
71.43%
Holding current value
$103,992
Previous $41,000
46.34%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
179Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$281 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$189 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$143 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$122 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$120 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.59B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...